Omega Healthcare Investors, Inc. – Consensus ‘buy’ rating and 4.6% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Omega Healthcare Investors, Inc. with ticker code (OHI) have now 15 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between $49.00 and $35.00 with the average target price sitting at $42.47. Given that the stocks previous close was at $40.61 and the analysts are correct then there would likely be a percentage uptick in value of 4.6%. The 50 day MA is $40.59 while the 200 day moving average is $35.46. The market capitalization for the company is 11.04B. The current share price for the company is: $39.81 USD

The potential market cap would be $11,547,564,112 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 29.27, revenue per share of $4.03 and a 3.9% return on assets.

Omega Healthcare Investors, Inc. is a real estate investment trust (REIT). The Company operates through the segment, which consists of investments in healthcare-related real estate properties located in the United States and the United Kingdom. The Company’s core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs). The Company’s portfolio consists of its long-term leases and real estate loans with healthcare operating companies and affiliates. In addition, the Company makes loans to operators and/or their principals. Its portfolio of real estate investments includes over 926 healthcare facilities, located in 42 states and the United Kingdom that are operated by 67 third-party operators.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search